PHARMExcel is an award-winning, ISO 9001:2015 certified, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company offers in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory, and other industry associates, allowing us to provide a global reach. We help world-class organisations. One of our core strengths is our commitment and approach. All our clients are treated the same, regardless of size or scope of work. We pride ourselves on fostering strong, collaborative relationships and consider ourselves an extension of your team. Praise from our clients.
| Website | http://www.pharmexcel-cro.com |
| Revenue | $1 million |
| Employees | 25 (16 on RocketReach) |
| Founded | 2009 |
| Industry | Research Services, Hospitals & Clinics, Medical Testing & Clinical Laboratories, Healthcare |
| Keywords | Clinical Research Organization, Contract Research Organization, Cro, Clinical Trials, Clinical Trial Management, Pharmaceutical Research, Drug Development, Biopharmaceutical Services, Full Service Cro, Clinical Trial Design, Data Management, Biostatistics, Regulatory Affairs, Pharmacovigilance, Medical Writing, Quality Assurance, Clinical Monitoring, Project Management, Iso 9001 |
| Competitors | ICON plc, Research Pharmaceutical Services, Syneos Health, PPD, Charles River Laboratories, Medpace, Covance, Worldwide Clinical Trials, WCG, Quintiles Transnational Holdings +36 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies |
Looking for a particular PHARMExcel employee's phone or email?
The PHARMExcel annual revenue was $1 million in 2026.
Yvanne Enever is the Founder and Chief Executive Officer of PHARMExcel.
16 people are employed at PHARMExcel.
The NAICS codes for PHARMExcel are [6215, 621, 62, 62151].
The SIC codes for PHARMExcel are [80, 807].